SlideShare a Scribd company logo
1 of 2
Download to read offline
About
Overview
Our Mission
Vision of Success
Company Values
History
Leadership
News
E-Newsletter
Corporate
Neuropharmacology
DMPK
Toxicology
Bioanalysis
Translational
Medicine
Early Stage Clinical
Phase II - IV Clinical
See You
QPS Tube
Social Media
Back
About  › News  › Early Stage Clinical
EARLY STAGE CLINICAL
Serial CSF Sampling over a Period of 30 h via an Indwelling Spinal Catheter in
Healthy Volunteers: Headache, Back Pain, Tolerability and Measured
Acetylcholine Profile
In Psychiatry and Neurology, serial cerebrospinal fluid (CSF) sampling can yield
important information on neuropeptides, neurotransmitters and metabolites.
Comparing levels of these biomarkers with pharmacokinetic data can help evaluate
medicinal interventions during drug development. Obtaining quality CSF samples to
test, however, poses some technical challenges.
QPS clinicians Izaak den Daas, Johan Wemer, Khalid Abou Farha and Wim Tamminga
co-reported a validation study of healthy volunteers to assess the feasibility, safety
and tolerability of serial CSF sampling. Their goal was to establish a standard
procedure to guide timed interval CSF sampling via an indwelling catheter, for
application in future drug development studies. At the same time, they wanted to
establish that this methodology produced usable CSF samples.
For the study, seven healthy male subjects aged 55–75 years were intravenously pre-
hydrated. Experienced, board-certified anesthesiologists inserted indwelling
intrathecal catheters. Blood and CSF samples were collected over 30 hours, and
subjects were given the antithrombotic Fraxiparine 12 and 36 hours after
catheterization. After removal of the catheter, subjects were kept lying down for 24
hours. Side effects were assessed by a series of questionnaires and by exit
interviews.
In general, subjects tolerated the procedure well, scoring low on the VAS (Visual
Analog Scale) for headache and back pain. Reported adverse effects were mild and
resolved before subjects left the clinic. Furthermore, all CSF samples tested reflected
non-negligible levels of Acetylcholine, an Alzheimer’s Disease-sensitive biomarker,
indicating that the CSF collected was of good quality.
Since the procedure resulted in no serious complications, was well-tolerated, and
produced high quality CSF samples, the authors concluded that their validation study
could form the basis for future patient studies requiring serial CSF sampling to
investigate disease mechanisms and the pharmacodynamics of developmental drugs.
Serial CSF Sampling over a Period of 30 h via an Indwelling Spinal Catheter in
Healthy Volunteers: Headache, Back Pain, Tolerability and Measured
Acetylcholine Profile
Renovation of Bioanalytical
Radiochemistry Laboratory
Attached to Phase I Unit in the
Netherlands Facilitates Top-Tier
Human Mass Balance Studies -
August 2013
Early Stage Clinical
Sunny Summer Update from QPS
MRA, the Largest Multi-Specialty
Clinical Research Center in the
United States - August 2013
Phase II - IV Clinical
Summer Update from the QPS
News
QPS Tube
Malignant Melanoma Therapy Gets
Personal
Common BRAF Mutation in
Melanoma Described Treatment
BRAF and MEK Inhibitor
Combination for Advanced
Melanoma
BRAF Targeted Therapy - Melanoma
Education Symposium
Website Enter text to search GO
contactlocationssolutionsservicesperformancequalityabout
Page 1 of 2Serial CSF sampling over a period of 30 h via an indwelling spinal catheter in healthy vol...
10/7/2013http://qps.com/abt_news_earlystage5.php
Home
Site Map
About
Overview
Our Mission
Vision of Success
Company Values
History
Leadership
News
See You
QPS Tube
Social Media
Quality
Quality Assurance
Compliance
Employee Qualifications
Performance
Testimonials
Experience
Project Management
Scientific Reference
Fresh from the Pipeline
Services
Neuropharmacology
DMPK
Toxicology
Bioanalysis
Translational Medicine
Early Stage Clinical
Phase II - IV Clinical
Solutions
Biosimilars
Neuroscience
Vaccines
IND Package
Radiolabel ADME
Dermal & Transdermal
Research Services
Locations
QPS Delaware USA
QPS Bio-Kinetic USA
QPS MRA USA
QPS Netherlands
QPS Taiwan
QPS CTPS Taiwan
QPS Qualitix Taiwan
QPS Bioserve India
QPS Austria
Contact
BD Office
Enroll In A Study
Careers
Submit RFP
Request Literature
2013 QPS Holdings. All Rights Reserved
Delaware Technology Park, 3 Innovation Way, Suite 240,Newark, DE 19711.
TEL + 1 302 369 5601. FAX + 1 302 369 5602
Page 2 of 2Serial CSF sampling over a period of 30 h via an indwelling spinal catheter in healthy vol...
10/7/2013http://qps.com/abt_news_earlystage5.php

More Related Content

What's hot

amylase poster
amylase posteramylase poster
amylase posterthad88
 
Immunotherapy for Metastatic Triple Negative Breast Cancer
Immunotherapy for Metastatic Triple Negative Breast CancerImmunotherapy for Metastatic Triple Negative Breast Cancer
Immunotherapy for Metastatic Triple Negative Breast Cancerbkling
 
Percepta sales aid pc133.1.1801
Percepta sales aid pc133.1.1801Percepta sales aid pc133.1.1801
Percepta sales aid pc133.1.1801Phil J. Morrison
 
Managing central venous access devices in cancer patients a practice guidelin...
Managing central venous access devices in cancer patients a practice guidelin...Managing central venous access devices in cancer patients a practice guidelin...
Managing central venous access devices in cancer patients a practice guidelin...Clinica de imagenes
 
New Thinking, New Strategies in Advanced Urothelial Carcinoma
New Thinking, New Strategies in Advanced Urothelial CarcinomaNew Thinking, New Strategies in Advanced Urothelial Carcinoma
New Thinking, New Strategies in Advanced Urothelial Carcinomai3 Health
 
A Paradigm Shift: Immunotherapy for Metastatic Melanoma – Michael K. Wong, MD...
A Paradigm Shift: Immunotherapy for Metastatic Melanoma – Michael K. Wong, MD...A Paradigm Shift: Immunotherapy for Metastatic Melanoma – Michael K. Wong, MD...
A Paradigm Shift: Immunotherapy for Metastatic Melanoma – Michael K. Wong, MD...Melanoma Research Foundation
 
Important trials of 2016
Important trials of 2016Important trials of 2016
Important trials of 2016Vibhay Pareek
 
Сравнение эффективности препаратов Карбоплатин (Carboplatin) и Паклитаксел (P...
Сравнение эффективности препаратов Карбоплатин (Carboplatin) и Паклитаксел (P...Сравнение эффективности препаратов Карбоплатин (Carboplatin) и Паклитаксел (P...
Сравнение эффективности препаратов Карбоплатин (Carboplatin) и Паклитаксел (P...oncoportal.net
 
Enhancing Treatment Experiences in Castration-Resistant Prostate Cancer: The ...
Enhancing Treatment Experiences in Castration-Resistant Prostate Cancer: The ...Enhancing Treatment Experiences in Castration-Resistant Prostate Cancer: The ...
Enhancing Treatment Experiences in Castration-Resistant Prostate Cancer: The ...i3 Health
 
Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016
Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016
Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016Dana-Farber Cancer Institute
 
QMU 2 : HPV Screening, May 2015
QMU 2 : HPV Screening, May 2015QMU 2 : HPV Screening, May 2015
QMU 2 : HPV Screening, May 2015Kok-Ming Choo
 
EuroBioForum 2013 - Day 1 | Greame Boyle
EuroBioForum 2013 - Day 1 | Greame BoyleEuroBioForum 2013 - Day 1 | Greame Boyle
EuroBioForum 2013 - Day 1 | Greame BoyleEuroBioForum
 

What's hot (18)

amylase poster
amylase posteramylase poster
amylase poster
 
Immunotherapy for Metastatic Triple Negative Breast Cancer
Immunotherapy for Metastatic Triple Negative Breast CancerImmunotherapy for Metastatic Triple Negative Breast Cancer
Immunotherapy for Metastatic Triple Negative Breast Cancer
 
Strengthening Our Grip on Immuno-Oncology in Genitourinary Cancers: Understan...
Strengthening Our Grip on Immuno-Oncology in Genitourinary Cancers: Understan...Strengthening Our Grip on Immuno-Oncology in Genitourinary Cancers: Understan...
Strengthening Our Grip on Immuno-Oncology in Genitourinary Cancers: Understan...
 
Percepta sales aid pc133.1.1801
Percepta sales aid pc133.1.1801Percepta sales aid pc133.1.1801
Percepta sales aid pc133.1.1801
 
article-le-pomit
article-le-pomitarticle-le-pomit
article-le-pomit
 
Managing central venous access devices in cancer patients a practice guidelin...
Managing central venous access devices in cancer patients a practice guidelin...Managing central venous access devices in cancer patients a practice guidelin...
Managing central venous access devices in cancer patients a practice guidelin...
 
New Thinking, New Strategies in Advanced Urothelial Carcinoma
New Thinking, New Strategies in Advanced Urothelial CarcinomaNew Thinking, New Strategies in Advanced Urothelial Carcinoma
New Thinking, New Strategies in Advanced Urothelial Carcinoma
 
A Paradigm Shift: Immunotherapy for Metastatic Melanoma – Michael K. Wong, MD...
A Paradigm Shift: Immunotherapy for Metastatic Melanoma – Michael K. Wong, MD...A Paradigm Shift: Immunotherapy for Metastatic Melanoma – Michael K. Wong, MD...
A Paradigm Shift: Immunotherapy for Metastatic Melanoma – Michael K. Wong, MD...
 
Important trials of 2016
Important trials of 2016Important trials of 2016
Important trials of 2016
 
Unraveling the Complex Treatment Landscape of Prostate Cancer: Guidance for D...
Unraveling the Complex Treatment Landscape of Prostate Cancer: Guidance for D...Unraveling the Complex Treatment Landscape of Prostate Cancer: Guidance for D...
Unraveling the Complex Treatment Landscape of Prostate Cancer: Guidance for D...
 
Сравнение эффективности препаратов Карбоплатин (Carboplatin) и Паклитаксел (P...
Сравнение эффективности препаратов Карбоплатин (Carboplatin) и Паклитаксел (P...Сравнение эффективности препаратов Карбоплатин (Carboplatin) и Паклитаксел (P...
Сравнение эффективности препаратов Карбоплатин (Carboplatin) и Паклитаксел (P...
 
Enhancing Treatment Experiences in Castration-Resistant Prostate Cancer: The ...
Enhancing Treatment Experiences in Castration-Resistant Prostate Cancer: The ...Enhancing Treatment Experiences in Castration-Resistant Prostate Cancer: The ...
Enhancing Treatment Experiences in Castration-Resistant Prostate Cancer: The ...
 
Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016
Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016
Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016
 
Gem ox panitumumab
Gem ox  panitumumabGem ox  panitumumab
Gem ox panitumumab
 
QMU 2 : HPV Screening, May 2015
QMU 2 : HPV Screening, May 2015QMU 2 : HPV Screening, May 2015
QMU 2 : HPV Screening, May 2015
 
EuroBioForum 2013 - Day 1 | Greame Boyle
EuroBioForum 2013 - Day 1 | Greame BoyleEuroBioForum 2013 - Day 1 | Greame Boyle
EuroBioForum 2013 - Day 1 | Greame Boyle
 
Future of medicine
Future of medicineFuture of medicine
Future of medicine
 
Liquid biopsy
Liquid biopsyLiquid biopsy
Liquid biopsy
 

Similar to QPS_EarlyStageClinical_serialCSFsampling

Pharmacokinetic Studies in Patients
Pharmacokinetic Studies in PatientsPharmacokinetic Studies in Patients
Pharmacokinetic Studies in PatientsQPS Holdings, LLC
 
Innovative clinical trial designs
Innovative clinical trial designs Innovative clinical trial designs
Innovative clinical trial designs Emad Shash
 
CDAC 2018 Elemento A precision medicine
CDAC 2018 Elemento A precision medicineCDAC 2018 Elemento A precision medicine
CDAC 2018 Elemento A precision medicineMarco Antoniotti
 
biomarcare_journal.pone.0159522.PDF
biomarcare_journal.pone.0159522.PDFbiomarcare_journal.pone.0159522.PDF
biomarcare_journal.pone.0159522.PDFOuriel Faktor
 
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...bkling
 
ca cervix screening.pptx
ca cervix screening.pptxca cervix screening.pptx
ca cervix screening.pptxSeemadas31
 
Towards efficient therapies for small cell long cancer dr. n. haraszkiewicz...
Towards efficient therapies for small cell long cancer   dr. n. haraszkiewicz...Towards efficient therapies for small cell long cancer   dr. n. haraszkiewicz...
Towards efficient therapies for small cell long cancer dr. n. haraszkiewicz...Dr. Natalia Haraszkiewicz-Birkemeier
 
TCGC The Clinical Genome Conference 2015
TCGC The Clinical Genome Conference 2015TCGC The Clinical Genome Conference 2015
TCGC The Clinical Genome Conference 2015Nicole Proulx
 
The Envisia Genomic Classifier
The Envisia Genomic ClassifierThe Envisia Genomic Classifier
The Envisia Genomic ClassifierPhil J. Morrison
 

Similar to QPS_EarlyStageClinical_serialCSFsampling (20)

QPS CSF Sampling
QPS CSF SamplingQPS CSF Sampling
QPS CSF Sampling
 
Pharmacokinetic Studies in Patients
Pharmacokinetic Studies in PatientsPharmacokinetic Studies in Patients
Pharmacokinetic Studies in Patients
 
Innovative clinical trial designs
Innovative clinical trial designs Innovative clinical trial designs
Innovative clinical trial designs
 
CDAC 2018 Elemento A precision medicine
CDAC 2018 Elemento A precision medicineCDAC 2018 Elemento A precision medicine
CDAC 2018 Elemento A precision medicine
 
CASC5 Is Elevated in Lung Adenocarcinoma and Confers Poor Patient Survival
CASC5 Is Elevated in Lung Adenocarcinoma and Confers Poor Patient SurvivalCASC5 Is Elevated in Lung Adenocarcinoma and Confers Poor Patient Survival
CASC5 Is Elevated in Lung Adenocarcinoma and Confers Poor Patient Survival
 
biomarcare_journal.pone.0159522.PDF
biomarcare_journal.pone.0159522.PDFbiomarcare_journal.pone.0159522.PDF
biomarcare_journal.pone.0159522.PDF
 
Cra helwan
Cra helwanCra helwan
Cra helwan
 
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
 
ca cervix screening.pptx
ca cervix screening.pptxca cervix screening.pptx
ca cervix screening.pptx
 
Towards efficient therapies for small cell long cancer dr. n. haraszkiewicz...
Towards efficient therapies for small cell long cancer   dr. n. haraszkiewicz...Towards efficient therapies for small cell long cancer   dr. n. haraszkiewicz...
Towards efficient therapies for small cell long cancer dr. n. haraszkiewicz...
 
JCO_Editorial_Nov2011
JCO_Editorial_Nov2011JCO_Editorial_Nov2011
JCO_Editorial_Nov2011
 
IPCR for cancer.pdf
IPCR for cancer.pdfIPCR for cancer.pdf
IPCR for cancer.pdf
 
MLBC vs CPS.pptx
MLBC vs CPS.pptxMLBC vs CPS.pptx
MLBC vs CPS.pptx
 
TCGC The Clinical Genome Conference 2015
TCGC The Clinical Genome Conference 2015TCGC The Clinical Genome Conference 2015
TCGC The Clinical Genome Conference 2015
 
The Envisia Genomic Classifier
The Envisia Genomic ClassifierThe Envisia Genomic Classifier
The Envisia Genomic Classifier
 
Dalton
DaltonDalton
Dalton
 
Dalton presentation
Dalton presentationDalton presentation
Dalton presentation
 
main.pdf
main.pdfmain.pdf
main.pdf
 
Asccp colposcopy standards___role_of_colposcopy,.3
Asccp colposcopy standards___role_of_colposcopy,.3Asccp colposcopy standards___role_of_colposcopy,.3
Asccp colposcopy standards___role_of_colposcopy,.3
 
SCLC CTC paper 2014
SCLC CTC paper 2014SCLC CTC paper 2014
SCLC CTC paper 2014
 

QPS_EarlyStageClinical_serialCSFsampling

  • 1. About Overview Our Mission Vision of Success Company Values History Leadership News E-Newsletter Corporate Neuropharmacology DMPK Toxicology Bioanalysis Translational Medicine Early Stage Clinical Phase II - IV Clinical See You QPS Tube Social Media Back About  › News  › Early Stage Clinical EARLY STAGE CLINICAL Serial CSF Sampling over a Period of 30 h via an Indwelling Spinal Catheter in Healthy Volunteers: Headache, Back Pain, Tolerability and Measured Acetylcholine Profile In Psychiatry and Neurology, serial cerebrospinal fluid (CSF) sampling can yield important information on neuropeptides, neurotransmitters and metabolites. Comparing levels of these biomarkers with pharmacokinetic data can help evaluate medicinal interventions during drug development. Obtaining quality CSF samples to test, however, poses some technical challenges. QPS clinicians Izaak den Daas, Johan Wemer, Khalid Abou Farha and Wim Tamminga co-reported a validation study of healthy volunteers to assess the feasibility, safety and tolerability of serial CSF sampling. Their goal was to establish a standard procedure to guide timed interval CSF sampling via an indwelling catheter, for application in future drug development studies. At the same time, they wanted to establish that this methodology produced usable CSF samples. For the study, seven healthy male subjects aged 55–75 years were intravenously pre- hydrated. Experienced, board-certified anesthesiologists inserted indwelling intrathecal catheters. Blood and CSF samples were collected over 30 hours, and subjects were given the antithrombotic Fraxiparine 12 and 36 hours after catheterization. After removal of the catheter, subjects were kept lying down for 24 hours. Side effects were assessed by a series of questionnaires and by exit interviews. In general, subjects tolerated the procedure well, scoring low on the VAS (Visual Analog Scale) for headache and back pain. Reported adverse effects were mild and resolved before subjects left the clinic. Furthermore, all CSF samples tested reflected non-negligible levels of Acetylcholine, an Alzheimer’s Disease-sensitive biomarker, indicating that the CSF collected was of good quality. Since the procedure resulted in no serious complications, was well-tolerated, and produced high quality CSF samples, the authors concluded that their validation study could form the basis for future patient studies requiring serial CSF sampling to investigate disease mechanisms and the pharmacodynamics of developmental drugs. Serial CSF Sampling over a Period of 30 h via an Indwelling Spinal Catheter in Healthy Volunteers: Headache, Back Pain, Tolerability and Measured Acetylcholine Profile Renovation of Bioanalytical Radiochemistry Laboratory Attached to Phase I Unit in the Netherlands Facilitates Top-Tier Human Mass Balance Studies - August 2013 Early Stage Clinical Sunny Summer Update from QPS MRA, the Largest Multi-Specialty Clinical Research Center in the United States - August 2013 Phase II - IV Clinical Summer Update from the QPS News QPS Tube Malignant Melanoma Therapy Gets Personal Common BRAF Mutation in Melanoma Described Treatment BRAF and MEK Inhibitor Combination for Advanced Melanoma BRAF Targeted Therapy - Melanoma Education Symposium Website Enter text to search GO contactlocationssolutionsservicesperformancequalityabout Page 1 of 2Serial CSF sampling over a period of 30 h via an indwelling spinal catheter in healthy vol... 10/7/2013http://qps.com/abt_news_earlystage5.php
  • 2. Home Site Map About Overview Our Mission Vision of Success Company Values History Leadership News See You QPS Tube Social Media Quality Quality Assurance Compliance Employee Qualifications Performance Testimonials Experience Project Management Scientific Reference Fresh from the Pipeline Services Neuropharmacology DMPK Toxicology Bioanalysis Translational Medicine Early Stage Clinical Phase II - IV Clinical Solutions Biosimilars Neuroscience Vaccines IND Package Radiolabel ADME Dermal & Transdermal Research Services Locations QPS Delaware USA QPS Bio-Kinetic USA QPS MRA USA QPS Netherlands QPS Taiwan QPS CTPS Taiwan QPS Qualitix Taiwan QPS Bioserve India QPS Austria Contact BD Office Enroll In A Study Careers Submit RFP Request Literature 2013 QPS Holdings. All Rights Reserved Delaware Technology Park, 3 Innovation Way, Suite 240,Newark, DE 19711. TEL + 1 302 369 5601. FAX + 1 302 369 5602 Page 2 of 2Serial CSF sampling over a period of 30 h via an indwelling spinal catheter in healthy vol... 10/7/2013http://qps.com/abt_news_earlystage5.php